As breast cancer is related to hormone and has different molecular types, we further divided patients into five separate subgroups based on molecular subtype, Ki67 status, ER status, PR status, and HER2 status to analyze the correlation between GLYAT expression and prognosis of breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.